Trial Profile
A retrospective study to evaluate the amrubicin monotherapy for patients with extrapulmonary neuroendocrine carcinoma after platinum-based chemotherapy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Dec 2015
Price :
$35
*
At a glance
- Drugs Amrubicin (Primary)
- Indications Colorectal cancer; Neuroendocrine tumours; Oesophageal cancer; Pancreatic cancer
- Focus Therapeutic Use
- 12 Dec 2015 New trial record